Theriva Biologics, Inc.
TOVX
$0.25
$0.014.52%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.53% | 73.43% | -37.89% | 21.03% | -13.74% |
| Total Receivables | -53.43% | 110.25% | -2.93% | 10.79% | -48.96% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -6.25% | 4.54% | -20.83% | 1.31% | -30.18% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -39.24% | -78.36% |
| Total Current Assets | -4.06% | 76.38% | -32.83% | 18.17% | -23.37% |
|
|
|||||
| Total Current Assets | -4.06% | 76.38% | -32.83% | 18.17% | -23.37% |
| Net Property, Plant & Equipment | 108.78% | -13.94% | -10.79% | -6.25% | -7.65% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.01% | 0.03% | -0.05% | 8.16% | 4.18% |
| Total Assets | 0.02% | 24.01% | -13.94% | 11.41% | -9.03% |
|
|
|||||
| Total Accounts Payable | -40.04% | 27.55% | 30.97% | 38.90% | -49.13% |
| Total Accrued Expenses | -3.45% | -20.32% | -13.75% | 126.14% | -4.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -10.07% | -10.22% | 1.05% | 7.92% | 3.17% |
| Total Finance Division Other Current Liabilities | 56.66% | 52.13% | -18.02% | -51.50% | 71.56% |
| Total Other Current Liabilities | 56.66% | 52.13% | -18.02% | -51.50% | 71.56% |
| Total Current Liabilities | 2.50% | -8.99% | -11.22% | 52.11% | 7.42% |
|
|
|||||
| Total Current Liabilities | 2.50% | -8.99% | -11.22% | 52.11% | 7.42% |
| Long-Term Debt | -2.69% | 1.03% | 0.92% | 8.98% | 1,534.78% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 332.39% | -18.71% | -25.86% | -20.22% | -16.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -12.77% | -1.72% | 3.95% | 68.63% | -18.81% |
| Total Liabilities | -0.03% | -5.15% | -4.40% | 51.27% | 2.33% |
|
|
|||||
| Common Stock & APIC | 0.65% | 2.93% | 0.14% | 1.93% | 0.03% |
| Retained Earnings | -0.57% | -0.56% | -1.24% | -3.85% | -1.29% |
| Treasury Stock & Other | -80.94% | -1.68% | -5.94% | 162.19% | 44.61% |
| Total Common Equity | 0.10% | 128.30% | -36.57% | -31.45% | -18.72% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.10% | 128.30% | -36.57% | -31.45% | -18.72% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.10% | 128.30% | -36.57% | -31.45% | -18.72% |
|
|
|||||